![Dan Liu](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Dan Liu is a Member-Supervisory Board at HitGen, Inc. He previously served as a Non-Executive Director at Wuhan YZY Biopharma Co., Ltd. Dr. Liu holds a doctorate degree from Vanderbilt University and Yale University, and an undergraduate degree from Nanjing University.
Anciens postes connus de Dan Liu
| Sociétés | Poste | Fin |
|---|---|---|
| HITGEN INC. | Directeur/Membre du Conseil | 28/06/2024 |
| WUHAN YZY BIOPHARMA CO., LTD. | Directeur/Membre du Conseil | 30/04/2024 |
Formation de Dan Liu
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
95
Relations au 1er degré
5
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Vanderbilt University
 Vanderbilt University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Yale University
 Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nanjing University
 Nanjing University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
HitGen, Inc.
 HitGen, Inc. BiotechnologyHealth Technology Develops innovative drugs | Health Technology |
Wuhan YZY Biopharma Co., Ltd.
 Wuhan YZY Biopharma Co., Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company which develops and commercializes immune-oncology therapies | Health Technology |
